Epidemiology of Cutaneous Human Papillomavirus Infections

  • Elsemieke I. Plasmeijer
  • Linda Struijk
  • Jan N. Bouwes Bavinck
  • Mariet C.W. Feltkamp
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

Human papillomaviruses (HPV) are small epitheliotropic DNA viruses. HPV infect keratinocytes in the skin as well as the mucosa. More than 100 different human papillomaviruses have been sequenced so far. Some HPV are involved in cancer development. HPV infection is particularly associated with anogenital cancer, most notably cervical cancer, but likely also with nonmelanoma skin cancer (NMSC). The beta papillomaviruses (beta-PV) are the most likely candidates to be involved in skin carcinogenesis.


Basal Cell Carcinoma Renal Transplant Recipient Actinic Keratose Organ Transplant Recipient Cutaneous Squamous Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shope R, Weston Hurst E. Infectious papillomatosis of rabbits. J Exp Med 1933; 58:607–624.CrossRefPubMedGoogle Scholar
  2. 2.
    Strauss MJ, Shaw EW. Crystalline virus-like particles from skin papillomas characterized by intranuclear inclusion bodies. Proc Soc Exp Biol Med 1949; 72(1):46–50.PubMedGoogle Scholar
  3. 3.
    zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92(9):690–698.PubMedCrossRefGoogle Scholar
  4. 4.
    De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324(1):17–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24S3:S1–S10.CrossRefGoogle Scholar
  6. 6.
    zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976; 36(2 pt 2):794.PubMedGoogle Scholar
  7. 7.
    Doorbar J. The papillomavirus life cycle. J Clin Virol 2005; 32:S7–S15.PubMedCrossRefGoogle Scholar
  8. 8.
    Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286(24):3106–3114.PubMedCrossRefGoogle Scholar
  9. 9.
    Jablonska S, Majewski S, Obalek S, Orth G. Cutaneous warts. Clin Dermatol 1997; 15(3):309–319.PubMedCrossRefGoogle Scholar
  10. 10.
    Larsson PA, Liden S. Prevalence of skin diseases among adolescents 12–16 years of age. Acta Dermatol Venereol 1980; 60(5):415–423.Google Scholar
  11. 11.
    Lai JY, Doyle RJ, Bluhm JM, Johnson JC. Multiplexed PCR genotyping of HPVs from plantaris verrucae. J Clin Virol 2006; 35(4):435–441.PubMedCrossRefGoogle Scholar
  12. 12.
    Jablonska S, Orth G. Cutaneous warts: clinical, histological and virological correlations. Arch Dermatol Res 1995; 287(6):616–618.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen SL, Tsao YP, Lee JW, Sheu WC, Liu YT. Characterization and analysis of human papillomaviruses of skin warts. Arch Dermatol Res 1993; 285(8):460–465.PubMedCrossRefGoogle Scholar
  14. 14.
    Jablonska S, Obalek S, Golebiowska A, Favre M, Orth G. Epidemiology of butchers’ warts. Arch Dermatol Res 1988; 280(Suppl):S24–S28.PubMedGoogle Scholar
  15. 15.
    Matsukura T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology 1992; 190(1):561–564.PubMedCrossRefGoogle Scholar
  16. 16.
    Pfister H. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003; 31:52–56.PubMedGoogle Scholar
  17. 17.
    Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108(5):712–715.PubMedCrossRefGoogle Scholar
  18. 18.
    Jong-Tieben LM, Berkhout RJ, Ter Schegget J, Vermeer BJ, de Fijter JW, Bruijn JA et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69(1):44–49.PubMedCrossRefGoogle Scholar
  19. 19.
    Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003; 41(6):2509–2514.PubMedCrossRefGoogle Scholar
  20. 20.
    Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumors and normal skin. J Gen Virol 1999; 80(pt 9):2437–2443.PubMedGoogle Scholar
  21. 21.
    Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18(6):362–374.PubMedCrossRefGoogle Scholar
  22. 22.
    Schmitt A, Rochat A, Zeltner R, Borenstein L, Barrandon Y, Wettstein FO et al. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol 1996; 70(3):1912–1922.PubMedGoogle Scholar
  23. 23.
    de Koning MN, Struijk L, Bouwes Bavinck JN, Kleter B, Ter Schegget J, Quint WG et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88(pt 5):1489–1495.PubMedCrossRefGoogle Scholar
  24. 24.
    Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2007; 127(1):116–119.PubMedCrossRefGoogle Scholar
  25. 25.
    Berkhout RJM, Bouwes Bavinck JN, Ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38(6):2087–2096.PubMedGoogle Scholar
  26. 26.
    Tieben LM, Ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42(2–3):265–279.PubMedCrossRefGoogle Scholar
  27. 27.
    Berkhout RJ, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33(3):690–695.PubMedGoogle Scholar
  28. 28.
    Boxman ILA, Russell A, Mulder LHC, Bouwes Bavinck JN, Ter Schegget J, Green A. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer 2000; 86(1):118–121.PubMedCrossRefGoogle Scholar
  29. 29.
    Shamanin V, Delius H, De Villiers EM. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994; 75(pt 5):1149–1156.PubMedCrossRefGoogle Scholar
  30. 30.
    Harwood CA, Spink PJ, Surentheran T, Leigh IM, De Villiers EM, McGregor JM et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37(11):3545–3555.PubMedGoogle Scholar
  31. 31.
    de Koning M, Quint W, Struijk L, Kleter B, Wanningen P, van Doorn LJ et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006; 44(5):1792–1800.PubMedCrossRefGoogle Scholar
  32. 32.
    Feltkamp MCW, Broer R, di Summa FM, Struijk L, Van der Meijden E, Verlaan BPJ et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63(10):2695–2700.PubMedGoogle Scholar
  33. 33.
    Struijk L, Hall L, van der ME, Wanningen P, Bouwes Bavinck JN, Neale R et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15(3):529–535.PubMedCrossRefGoogle Scholar
  34. 34.
    Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98(6):389–395.PubMedGoogle Scholar
  35. 35.
    Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO et al. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem 2005; 51(10):1845–1853.PubMedCrossRefGoogle Scholar
  36. 36.
    Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M, Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A 1978; 75(3):1537–1541.PubMedCrossRefGoogle Scholar
  37. 37.
    Orth G, Jablonska S, Jarzabek-Chorzelska M, Obalek S, Rzesa G, Favre M et al. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979; 39(3):1074–1082.PubMedGoogle Scholar
  38. 38.
    Majewski S, Jablonska S, Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 1997; 15(3):321–334.PubMedCrossRefGoogle Scholar
  39. 39.
    Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1(8379):702–705.PubMedCrossRefGoogle Scholar
  40. 40.
    Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; 2(8656):224–225.PubMedCrossRefGoogle Scholar
  41. 41.
    Hartevelt MM, Bouwes Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49(3):506–509.PubMedCrossRefGoogle Scholar
  42. 42.
    Harwood CA, McGregor JM, Proby CM, Breuer J. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999; 52(4):249–253.PubMedCrossRefGoogle Scholar
  43. 43.
    Rudlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115(6):681–692.PubMedCrossRefGoogle Scholar
  44. 44.
    Gassenmaier A, Fuchs P, Schell H, Pfister H. Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Dermatol Res 1986; 278(3):219–223.PubMedCrossRefGoogle Scholar
  45. 45.
    Bouwes Bavinck JN, Vermeer BJ, Vanderwoude FJ, Vandenbroucke JP, Schreuder GMT, Thorogood J et al. Relation between skin-cancer and hla antigens in renal-transplant recipients. N Engl J Med 1991; 325(12):843–848.PubMedGoogle Scholar
  46. 46.
    Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transplant Int 2003; 16(3):146–153.CrossRefGoogle Scholar
  47. 47.
    de Jong-Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105(3):367–371.PubMedCrossRefGoogle Scholar
  48. 48.
    Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61(3):289–297.PubMedCrossRefGoogle Scholar
  49. 49.
    Struijk L, Bouwes Bavinck JN, Wanningen P, Van der Meijden E, Westendorp RGJ, Ter Schegget J et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 2003; 121(6):1531–1535.PubMedCrossRefGoogle Scholar
  50. 50.
    Hall L, Struijk L, Neale RE, Feltkamp MC. Re: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98(19):1425–1426.PubMedGoogle Scholar
  51. 51.
    Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003; 295(7):273–279.PubMedCrossRefGoogle Scholar
  52. 52.
    Wieland U, Ritzkowsky A, Stoltidis M, Weissenborn S, Stark S, Ploner M et al. Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000; 115(1):124–128.PubMedCrossRefGoogle Scholar
  53. 53.
    Forslund O, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" biopsies from the same tumors. J Invest Dermatol 2004; 123(2):388–394.PubMedCrossRefGoogle Scholar
  54. 54.
    Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150(5):949–957.PubMedCrossRefGoogle Scholar
  55. 55.
    Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, Burk RD et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121(8):1862–1868.PubMedCrossRefGoogle Scholar
  56. 56.
    Bouwes Bavinck JN, De Boer A, Vermeer BJ, Hartevelt MM, van der Woude FJ, Claas FH et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129(3):242–249.CrossRefGoogle Scholar
  57. 57.
    Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991; 88(22):10124–10128.PubMedCrossRefGoogle Scholar
  58. 58.
    Marks R. Squamous cell carcinoma. Lancet 1996; 347(9003):735–738.PubMedCrossRefGoogle Scholar
  59. 59.
    Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996; 144(11):1034–1040.PubMedGoogle Scholar
  60. 60.
    Boxman ILA, Russell A, Mulder LHC, Bouwes Bavinck JN, Ter Schegget J, Green A. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 2001; 117(5):1108–1112.PubMedCrossRefGoogle Scholar
  61. 61.
    Termorshuizen F, Feltkamp MC, Struijk L, de Gruijl FR, Bouwes Bavinck JN, van Loveren H. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 2004; 122(6):1456–1462.PubMedCrossRefGoogle Scholar
  62. 62.
    Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125(1):93–97.PubMedCrossRefGoogle Scholar
  63. 63.
    Forslund O, Ly H, Higgins G. Improved detection of cutaneous human papillomavirus DNA by single tube nested ‘hanging droplet’ PCR. J Virol Methods 2003; 110(2):129–136.PubMedCrossRefGoogle Scholar
  64. 64.
    Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14(23):3065–3073.PubMedCrossRefGoogle Scholar
  65. 65.
    Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74(24):11636–11641.PubMedCrossRefGoogle Scholar
  66. 66.
    Shamanin V, zur HH, Lavergne D, Proby CM, Leigh IM, Neumann C et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88(12):802–811.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Elsemieke I. Plasmeijer
    • 1
  • Linda Struijk
    • 2
  • Jan N. Bouwes Bavinck
    • 3
  • Mariet C.W. Feltkamp
    • 1
  1. 1.Department of Medical MicrobiologyLeiden University Medical CenterThe Netherlands
  2. 2.DDL Diagnostic LaboratoryThe Netherlands
  3. 3.Department of DermatologyLeiden University Medical CenterThe Netherlands

Personalised recommendations